![]() |
市場調查報告書
商品編碼
2035282
微生物土壤改良劑市場預測至2034年—按產品類型、作物類型、應用方法、製劑形式、最終用戶和地區分類的全球分析Microbial Soil Enhancers Market Forecasts to 2034 - Global Analysis By Product Type, Crop Type, Treatment, Formulation, End User and By Geography |
||||||
根據 Stratistics MRC 預測,全球微生物土壤改良劑市場預計到 2026 年將達到 54 億美元,並在預測期內以 16.7% 的複合年成長率成長,到 2034 年達到 186 億美元。
微生物土壤改良劑是指含有有益土壤微生物的農業生技藥品。這些製劑包括細菌、真菌、菌根真菌、放線菌、菌叢以及液體生物肥料。這些產品能夠改善土壤健康,透過生物固氮、磷酸鹽溶解和鉀元素吸收等機制來提高植物對養分的利用效率,透過競爭性排斥抑制土壤病原體,透過促進植物激素的產生來促進植物生長,並建立長期穩定的土壤有機質和微生物多樣性,從而支持永續和可再生農業種植系統。
再生農業對生物材料的需求
商業農戶、農業機構和採購商迅速採用以恢復土壤生物健康為優先的再生農業實踐,從而持續推動了對微生物土壤改良劑的需求。這些改良劑能夠恢復因數十年來合成化學品使用而喪失的土壤微生物群落多樣性。大型食品品牌和零售商越來越要求供應商農場的生物實踐獲得認證,作為其供應鏈永續性計畫的一部分,這在整個供應鏈(從農場到零售)中催生了對經認證的微生物土壤健康產品的市場需求。
土壤環境導致應用條件改變
微生物土壤改良劑的有效性存在差異,這源於土壤pH值、有機質含量、水分狀況以及土壤特有的微生物群落組成的不同,從而給田間試驗結果的可重複性和一致性帶來了挑戰。這不僅使得產品性能保證難以建立,也使得在單一農場作業中,難以預測在不斷變化的田間條件下產品的效果,因此無法滿足可靠的投資回報率(ROI)預期。這導致農民對高價生物土壤產品採取規避風險的態度。
碳匯專案中的土壤健康證明
在農業排碳權計畫中,採用檢驗的土壤微生物群落改善作為增強認證碳固存實踐的指標,為微生物土壤改良劑產品創造了市場拓展機會。這些產品的應用可被記錄為檢驗的土壤改良措施,從而對碳匯成果產生可衡量的貢獻,使參與農業碳市場基礎設施項目的微生物土壤改良劑品牌能夠開發新的收入來源。
與傳統合成肥料的競爭
傳統合成肥料之所以佔據市場主導地位,是因為其作物反應高度可預測,已被農藝師廣泛推薦,且單位施用成本遠低於高階微生物土壤改良劑。因此,生物土壤健康替代方案在對成本高度敏感的農業市場中難以獲得市場佔有率。在這些市場中,主要作物的經濟效益限制了農民的承受能力,除非有可靠的田間試驗證據證明其具有令人信服的投資回報,否則他們無法承擔對高階生物材料的投資。
新冠疫情導致的供應鏈中斷,影響了合成肥料的供應並導致價格大幅上漲,這促使農業部門更加關注生物土壤健康替代方案,以減少全球對合成肥料供應鏈的依賴。疫情後再生農業計畫的擴展、碳市場的開發以及消費者對永續食品日益成長的需求(這提高了零售商供應鏈的永續性要求),持續推動著全球商業農業和轉型農業企業中微生物土壤改良劑市場的成長。
在預測期內,聯合微生物製劑細分市場預計將佔據最大的市場佔有率。
預計在預測期內,多菌株微生物製劑將佔據最大的市場佔有率。與單菌株生物肥料相比,多菌株微生物製劑結合了互補的營養循環、生長促進和病原體抑制功能集,能夠提供更優異且更穩定的農業化學品性能。多菌株產品在各種土壤條件和作物類型中均展現出卓越的商業性功效,這促使農業專家不斷推薦,並增強了農民對其使用的信心,從而支撐了其高價位和在該細分市場收入中的領先地位。
在預測期內,糧食板塊預計將呈現最高的複合年成長率。
在預測期內,糧食產業預計將呈現最高的成長率。這主要歸功於關鍵糧食供應鏈正在積極滿足食品公司對永續性採購的要求,並鼓勵採用生物土壤健康管理技術;此外,越來越多的田間試驗證據表明,在主要糧食產區施用微生物增產劑能夠持續提高產量並改善土壤健康。
在預測期內,北美預計將佔據最大的市場佔有率。這是因為美國擁有成熟的生物土壤改良劑產業,諾維信、BASF和科迪華等主要公司在國內生物材料銷售額顯著;先進的商業穀物生產商已根深蒂固地接受了再生農業理念;此外,完善的農產品分銷基礎設施也使得微生物產品能夠廣泛市場進入各種作物生產系統。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸因於以下幾個因素:印度、中國和東南亞國家大規模實施有機和永續農業項目,這些項目需要引入生物材料;國內生物農業材料產業的成長;出口市場對永續性的要求,為在亞洲主要出口農作物生產中採用微生物土壤健康管理創造了商業性獎勵;以及政府對有機農業的補貼,推動了採用經認證的生物土壤改良劑產品的轉型項目。
According to Stratistics MRC, the Global Microbial Soil Enhancers Market is accounted for $5.4 billion in 2026 and is expected to reach $18.6 billion by 2034 growing at a CAGR of 16.7% during the forecast period. Microbial soil enhancers refer to agricultural biological products containing bacterial, fungal, mycorrhizal, actinomycetes, consortium, and liquid biofertilizer formulations of beneficial soil microorganisms that improve soil health, enhance plant nutrient availability through biological nitrogen fixation, phosphate solubilization, and potassium mobilization mechanisms, suppress soil-borne pathogens through competitive exclusion, promote plant growth through phytohormone production, and build long-term soil organic matter and microbial diversity in support of sustainable and regenerative agricultural cropping systems.
Regenerative Agriculture Biological Input Demand
Rapidly expanding commercial farmer and institutional agricultural buyer adoption of regenerative farming practices that mandate soil biological health restoration is creating sustained demand for microbial soil enhancer products that replenish depleted soil microbiome diversity from decades of synthetic chemical use. Supply chain sustainability program requirements from major food brands and retailers requiring supplier farm biological practice certification are generating market pull through entire supply chains from farm to retail for certified microbial soil health product adoption.
Soil Environment Application Variability
Microbial soil enhancer efficacy variability across diverse soil pH levels, organic matter content, moisture conditions, and indigenous microbial community compositions creates inconsistent field trial result reproducibility that challenges product performance guarantee development and generates farmer risk aversion toward premium biological soil products whose results are insufficiently predictable across variable field conditions within individual farm operations to justify reliable return-on-investment expectations.
Carbon Program Soil Health Documentation
Agricultural carbon credit program adoption of verified soil microbiome health improvement as a recognized carbon sequestration practice enhancement metric creates a market expansion opportunity for microbial soil enhancer products whose application can be documented as a verified soil health intervention generating measurable carbon outcome contribution, enabling additional revenue stream development for microbial enhancer brands participating in agricultural carbon market infrastructure programs.
Conventional Synthetic Fertilizer Competition
Conventional synthetic fertilizer market dominance with highly predictable crop response, established agronomist recommendation familiarity, and substantially lower per-unit application costs compared to premium microbial soil enhancer products creates significant market share capture barriers for biological soil health alternatives in cost-sensitive agricultural markets where commodity crop economics limit farmer capacity to absorb premium biological input investment unless robust local trial evidence demonstrates compelling return on investment.
COVID-19 supply chain disruptions affecting synthetic fertilizer availability and generating significant price spikes created agricultural sector interest in biological soil health alternatives reducing dependency on global synthetic fertilizer supply chains. Post-pandemic regenerative agriculture program expansion, carbon market development, and growing consumer sustainable food demand amplifying retailer supply chain sustainability requirements continue driving microbial soil enhancer market growth across commercial and transitioning farming operations globally.
The consortium microbial formulations segment is expected to be the largest during the forecast period
The consortium microbial formulations segment is expected to account for the largest market share during the forecast period, due to the superior and more consistent agronomic performance of multi-species microbial consortia combining complementary nutrient cycling, growth promotion, and pathogen suppression functional groups compared to single-species biofertilizer alternatives. The proven commercial efficacy of multi-strain products across diverse soil conditions and crop types generates stronger agronomist recommendation and farmer adoption confidence that sustains premium pricing and segment revenue leadership.
The cereals & grains segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the cereals & grains segment is predicted to witness the highest growth rate, driven by large-scale commercial farmer adoption of biological soil enhancers within wheat, corn, and soybean cropping systems as major grain supply chains respond to food company sustainability procurement requirements incentivizing biological soil health practice adoption, combined with expanding field trial evidence demonstrating consistent yield and soil health improvement outcomes from microbial enhancer application in major grain production geographies.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting a mature biological soil enhancer industry with leading companies including Novozymes, BASF, and Corteva generating substantial domestic biological input revenue, strong regenerative agriculture adoption culture among progressive commercial grain producers, and well-developed agribusiness distribution infrastructure enabling broad microbial product market access across diverse crop production systems.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to India, China, and Southeast Asian countries implementing large-scale organic and sustainable agriculture programs requiring biological input adoption, growing domestic biological agricultural input industries, export market sustainability requirements creating commercial incentive for microbial soil health adoption in major Asian agricultural export crop production, and government organic farming subsidies driving conversion programs incorporating certified biological soil enhancer products.
Key players in the market
Some of the key players in Microbial Soil Enhancers Market include BASF SE, Bayer AG, Syngenta Group, Corteva Agriscience, UPL Limited, Nutrien Ltd., Novozymes A/S, Valagro S.p.A., Koppert Biological Systems, Rizobacter Argentina S.A., Lallemand Inc., Terramax Inc., Bioceres Crop Solutions, Chr. Hansen Holding A/S, Sumitomo Chemical Co. Ltd., Italpollina S.p.A., and Mapleton Agri Biotec.
In March 2026, Novozymes A/S launched a new consortium biofertilizer combining nitrogen-fixing Bradyrhizobium, phosphate-solubilizing Bacillus, and mycorrhizal fungi in a single seed treatment application for corn and soybean production systems.
In February 2026, Bioceres Crop Solutions expanded its biological soil enhancement product portfolio with a new liquid microbial consortium formulation targeting drought-stressed soil conditions with validated performance across South American soybean and wheat production.
In December 2025, Koppert Biological Systems secured a major European organic grain cooperative supply agreement providing certified organic microbial soil enhancer programs across 200,000 hectares of transitioning conventional grain production.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.